The present work aims to calculate the fair value of the shares of the company Odontoprev, listed on the Brazilian stock exchange (B3) under the code ODPV3. Said calculation was made using a valuation technique, specifically using the Discounted Cash Flow (DCF) methodology. The information that served as the basis for this work had as its main origin technical and accounting documents, provided on the company's own Investor Relations website, in relation to the years 2013 to 2023, in addition to institutions of official and academic entities. Projections were made for the next ten years, based on the firm's past performance and values projected in the income statements presented by the company. Considering the assumptions adopted in this study, the resulting value is R$8.91 per share. Therefore, this analysis suggests that the company may be slightly overvalued, taking into account the risks associated with the company.
